Greenwich Wealth Management LLC Agenus Inc Transaction History

Greenwich Wealth Management LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$0.53 - $0.93 $2,385 - $4,185	4,500 Added 21.43%	25,500 $15,000
Q4 2023 Feb 01, 2024	SELL	$0.63 - $1.14 $8,064 - $14,591	-12,800 Reduced 37.87%	21,000 $17,000
Q3 2023 Nov 07, 2023	BUY	$1.12 - $1.88 $8,512 - $14,288	7,600 Added 29.01%	33,800 $38,000
Q2 2023 Jul 31, 2023	BUY	$1.31 - $2.04 $5,240 - $8,160	4,000 Added 18.02%	26,200 $42,000
Q1 2023 Apr 24, 2023	BUY	$1.45 - $2.95 $8,555 - $17,405	5,900 Added 36.2%	22,200 $34,000
Q2 2022 Aug 08, 2022	BUY	$1.3 - $2.64 $260 - $528	200 Added 1.24%	16,300 $32,000
Q1 2022 May 11, 2022	SELL	$2.35 - $3.47 $1,884 - $2,782	-802 Reduced 4.75%	16,100 $40,000
Q4 2021 Jan 28, 2022	BUY	$2.92 - $5.74 $2,338 - $4,597	801 Added 4.97%	16,902 $54,000
Q3 2021 Oct 19, 2021	BUY	$4.98 - $6.63 $5,233 - $6,968	1,051 Added 6.98%	16,101 $85,000
Q2 2021 Jul 27, 2021	BUY	$2.56 - $5.49 $2,688 - $5,764	1,050 Added 7.5%	15,050 $83,000
Q1 2021 May 06, 2021	BUY	$2.69 - $5.25 $5,108 - $9,969	1,899 Added 15.69%	14,000 $38,000
Q4 2020 Feb 12, 2021	BUY	$3.17 - $4.49 $38,360 - $54,333	12,101 New	12,101 $38,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Greenwich Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Greenwich Wealth Management LLC with notifications on news.